Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Auspex Pharmaceuticals Inc.

Auspex Pharmaceuticals Inc. (ASPX)

Market is closed
News
  • Displaying 7
Deerfield Management's Top Health Stocks ~ Auspex Pharmaceuticals Inc (ASPX), Horizon Pharma PLC (HZNP), AbbVie Inc (ABBV)

Deerfield Management's Top Health Stocks ~ Auspex Pharmaceuticals Inc (ASPX), Horizon Pharma PLC (HZNP), AbbVie Inc (ABBV)

James Flynn's Deerfield Management has filed its 13F with the SEC for the reporting period of March 31, with the investment manager disclosing a public equity portfolio valued at $3.09 billion.

Keep Reading →

May 29th, 2015 - Hedge Funds News

Pharmacyclics, Inc. (PCYC), Horizon Pharma PLC (HZNP), Auspex Pharmaceuticals Inc (ASPX): Hedge Fund's Cashing In On Highest Q1 Gainers

Pharmacyclics, Inc. (PCYC), Horizon Pharma PLC (HZNP), Auspex Pharmaceuticals Inc (ASPX): Hedge Fund's Cashing In On Highest Q1 Gainers

The first quarter is up, and our data analytics show that the top three gainers for the quarter were all biotechnology or biopharmaceutical companies and included Pharmacyclics, Inc.

Keep Reading →

April 2nd, 2015 - Hedge Funds News

Biotech Hedge Fund Deerfield Management's Top Stock Picks

Biotech Hedge Fund Deerfield Management's Top Stock Picks

James E. Flynn's Deerfield Management is one of the funds that is focused on the healthcare sector, investing around 70% of its portfolio in healthcare stocks.

Keep Reading →

February 28th, 2015 - Hedge Funds News

Auspex Pharmaceuticals Inc (ASPX): Deerfield Management Increase its Stake Following the Latest Public Offering of Stock

Auspex Pharmaceuticals Inc (ASPX): Deerfield Management Increase its Stake Following the Latest Public Offering of Stock

James E. Flynn’s Deerfield Management recently increased its stake in Auspex Pharmaceuticals Inc (NASDAQ:ASPX) by 1.5 million shares at $56.5 per share. According to the Form 4 filed with the U.S.

Keep Reading →

February 2nd, 2015 - Hedge Funds News

Deerfield Management Further Raises Its Position in Auspex Pharmaceuticals Inc (ASPX)

Deerfield Management Further Raises Its Position in Auspex Pharmaceuticals Inc (ASPX)

James E. Flynn’s Deerfield Management, in a filing with the Securities and Exchange Commission, reported further raising its stake Auspex Pharmaceuticals Inc (NASDAQ:ASPX).

Keep Reading →

February 12th, 2014 - Hedge Funds News

Deerfield Management Adds Cara Therapeutics Inc. (CARA) To Its Equity Portfolio

Deerfield Management Adds Cara Therapeutics Inc. (CARA) To Its Equity Portfolio

James E. Flynn’s Deerfield Management, in a filing with the Securities and Exchange Commission, reported a position in Cara Therapeutics Inc. (NASDAQ:CARA).

Keep Reading →

February 10th, 2014 - Hedge Funds News

Deerfield Management Discloses Stake in Post-IPO Auspex Pharmaceuticals Inc (ASPX)

Deerfield Management Discloses Stake in Post-IPO Auspex Pharmaceuticals Inc (ASPX)

James E. Flynn's Deerfield Management has revealed holding shares of Auspex Pharmaceuticals Inc (NASDAQ:ASPX), a company that went public today, on February 5.

Keep Reading →

February 5th, 2014 - Hedge Funds News

Insider Monkey Quarterly Strategy
+336.2% Insider Monkey Quarterly Strategy
+144.8% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)